Inhibition of cytosolic human forebrain choline acetyltransferase activity by phospho-l-serine: A phosphomonoester that accumulates during early stages of alzheimer's disease
- 31 August 1993
- journal article
- Published by Elsevier in Neurobiology of Aging
- Vol. 14 (4) , 367-372
- https://doi.org/10.1016/0197-4580(93)90123-s
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Actions of phosphomonoesters on CA1 hippocampal neurons as revealed by a combined electrophysiological and nuclear magnetic resonance studySynapse, 1991
- L‐Phosphoserine, a Metabolite Elevated in Alzheimer's Disease, Interacts with Specific L‐Glutamate Receptor SubtypesJournal of Neurochemistry, 1991
- Correlation between 31P NMR Phosphomonoester and Biochemically Determined Phosphorylethanolamine and Phosphatidylethanolamine during Development of the Rat BrainDevelopmental Neuroscience, 1988
- 31P Nuclear Magnetic Resonance Spectroscopic Investigation of Human Neuroblastoma in SituNew England Journal of Medicine, 1985
- Phosphorylethanolamine ‐ the major constituent of the phosphomonoester peak observed by 31P‐NMR on developing dog brainFEBS Letters, 1984
- NMR study of in vivo RIF-1 tumorsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1984
- NON-INVASIVE INVESTIGATION OF CEREBRAL METABOLISM IN NEWBORN INFANTS BY PHOSPHORUS NUCLEAR MAGNETIC RESONANCE SPECTROSCOPYThe Lancet, 1983
- The Cholinergic Hypothesis of Geriatric Memory DysfunctionScience, 1982
- Biochemistry of Alzheimer's DementiaJournal of Neurochemistry, 1982
- A rapid radiochemical method for the determination of choline acetyltransferaseJournal of Neurochemistry, 1975